Paydirt
DB
Insider

Daniella Beckman

Chief Financial Officer

Daniella Beckman (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $125K of TNGX (10,204 sh × $12.26, as filed), executed Feb 3.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$125K
shares × price, as filed
Last traded
Feb 3
Filed Feb 4

Median ADV $98.9M across their filed names

Open performance→
Volume by month
$125K$63K$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · sells $125K
Buys $0 Sells $125K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TNGX Tango Therapeutics, Inc. TNGX · 0 buys · 1 sell 1 filing
Recent filings
TNGXSALE Tango Therapeutics, Inc. View filing → $125K
10,204 sh × $12.26
Exec Feb 3
Filed Feb 4 · 5:30 PM ET